Doctor profile · Federal record
Dr. Melissa Veneracion, PA-C
Physician Assistant · Annapolis, MD
- NPI 1427263102
- Accepts Medicare
- MIPS 87.7 / 100 · 2023
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
101 Ridgely Ave, Suite 10
Annapolis, MD 214011409
(410) 263-5439
fax (410) 263-7482
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Maryland #C0002907
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427263102. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,003
Distinct HCPCS
10
Medicare allowed
$159,641
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,086 | 172 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 577 | 396 | $79 | |
17000 |
Destruction of precancer skin growth, 1 growth | 280 | 208 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 198 | 164 | $83 | |
17110 |
Destruction of skin growth, 1-14 growths | 177 | 146 | $97 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 164 | 101 | $111 | |
11103 |
Biopsy of related skin growth, each additional growth | 89 | 52 | $45 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 71 | 64 | $49 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | 27 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 60 | 42 | $148 |
In context: peer comparison
Among 26 peers in Annapolis Physician Assistant, average services per provider: 253. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$5,381
Transactions
128
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | 18 | $2,896.53 | |
| Janssen Biotech, INC. | 13 | $375.72 | |
| Ucb, INC. | 19 | $356.62 | |
| Novartis Pharmaceuticals Corporation | 14 | $273.48 | |
| Genzyme Corporation | 8 | $221.08 | |
| Abbvie INC. | 10 | $205.10 | |
| Pfizer INC. | 10 | $187.82 | |
| Lilly USA, LLC | 4 | $161.45 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $154.55 | |
| Incyte Corporation | 8 | $135.73 | |
| Sanofi-Aventis U.S. LLC | 1 | $85.00 | |
| Leo Pharma INC. | 3 | $74.04 | |
| Arcutis Biotherapeutics, INC. | 4 | $66.20 | |
| Medimetriks Pharmaceuticals, INC. | 3 | $64.46 | |
| Amgen INC. | 2 | $47.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
240
Patients
119
Total drug cost
$10,641
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 57 | 42 | $594 |
| Ketoconazole | Generic | 42 | 26 | $797 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 33 | 12 | $1,044 |
| Clobetasol Propionate | Generic | 28 | 22 | $1,858 |
| Clindamycin Phosphate | Generic | 19 | 0 | $818 |
| Metronidazole | Generic | 19 | 0 | $1,588 |
| Cephalexin | Generic | 18 | 17 | $250 |
| Nystatin | Generic | 13 | 0 | $442 |
| Pimecrolimus | Generic | 11 | 0 | $3,249 |
Frequently asked questions
What is Dr. Melissa Veneracion's medical specialty?
Dr. Melissa Veneracion practices Physician Assistant in Annapolis, MD.
Where does Dr. Melissa Veneracion practice?
Dr. Melissa Veneracion practices at 101 Ridgely Ave, Annapolis, MD 214011409. Office phone: 4102635439.
What is Dr. Melissa Veneracion's NPI?
Dr. Melissa Veneracion's National Provider Identifier (NPI) is 1427263102, issued by NPPES.
Does Dr. Melissa Veneracion accept Medicare assignment?
Yes. Dr. Melissa Veneracion accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melissa Veneracion commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.